Incyte (INCY) investor plans NASDAQ sale of 15,888 common shares

Rhea-AI Filing Summary

A shareholder of Incyte Corporation (INCY) has filed to potentially sell 15,888 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The planned sale, with an aggregate market value of $1,901,833.32, is listed for NASDAQ with an anticipated sale date of 07/31/2026. The securities include 12,181 restricted stock shares dated 07/14/2024 and 3,707 performance shares dated 07/14/2026.

Key Figures

Shares to be sold: 15,888 shares Aggregate market value: $1,901,833.32 Proposed sale date: 07/31/2026 +2 more

5 metrics

Shares to be sold 15,888 shares Common stock indicated for potential sale via NASDAQ

Aggregate market value $1,901,833.32 Value associated with 15,888 common shares to be sold

Proposed sale date 07/31/2026 Anticipated date of NASDAQ sale

Restricted stock referenced 12,181 shares Restricted stock dated 07/14/2024

Performance shares referenced 3,707 shares Performance shares dated 07/14/2026

Key Terms

Restricted Stock, Performance Shares, Executive Financial Services, Securities To Be Sold

4 terms

Restricted Stock financial

"Common | 07/14/2024 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 07/14/2026 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/31/2026 - 04:05 PM Accepted by SEC EDGAR 07/31/2026 - 04:04 PM Learn about SEC filing dates

FAQ

What stock sale is being planned for Incyte (INCY)?

A shareholder has filed to potentially sell 15,888 shares of Incyte common stock. The filing lists the sale as occurring on 07/31/2026 through NASDAQ, using Morgan Stanley Smith Barney LLC Executive Financial Services.

What is the approximate value of the planned Incyte (INCY) share sale?

The planned sale covers Incyte common stock with an aggregate market value of $1,901,833.32. This value corresponds to the 15,888 shares referenced in the filing for a potential NASDAQ transaction.

Which broker is handling the potential Incyte (INCY) share sale?

The potential sale of 15,888 Incyte shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the executing broker.

What types of equity awards are involved in this Incyte (INCY) Form 144 filing?

The filing references restricted stock and performance shares. It lists 12,181 restricted stock shares dated 07/14/2024 and 3,707 performance shares dated 07/14/2026 as related securities.

On which exchange is the Incyte (INCY) stock expected to be sold?

The shares covered by this filing are expected to be sold on NASDAQ. The filing links the 15,888 Incyte common shares and their aggregate value of $1,901,833.32 to a NASDAQ transaction date of 07/31/2026.

How many Incyte (INCY) restricted stock and performance shares are referenced?

The document lists 12,181 restricted stock shares with a date of 07/14/2024 and 3,707 performance shares with a date of 07/14/2026. These figures relate to the securities underlying the planned sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15888	1901833.32	202697746	07/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/14/2024	Restricted Stock	Issuer			12181	07/14/2024	Not Applicable
Common	07/14/2026	Performance Shares	Issuer			3707	07/14/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)